| - | raised natriuretic peptide level is evidence of heart failure (highly sensitive) |
| - | elevated NT-proBNP after an anthracycline identifies patients at risk of CTRCD |
| - | CTRCD is not limited to high-dose regimes |
| - | persistent elevations after 72 hrs predict progressive decline in left ventricular failure |
| - | raised levels are associated with a greater risk of developing trastuzumab CTRCD |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.